Eli Lilly wants Korean scientists in their InnoCentive Challenges

Published: 2002-06-14 06:57:00

Updated: 2002-06-14 06:57:00

Eli Lilly and Company, a US-based multinational company, has recently expressed its keen interest in attracting more Korean scientists involved in the medical, chemical and biological fields, in line with their R&D internet projects promoted by InnoCentive (www.innoCentive.com), an e-business ven...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK